According to Gram Research analysis, a 2026 retrospective cohort study of over 633,000 adults found that people with vitamin D deficiency had a 53% higher risk of developing pancreatic cancer within 10 years compared to those with healthy vitamin D levels. The risk was even stronger for people with severe deficiency, who had more than double the risk. While these findings suggest maintaining adequate vitamin D may help protect pancreatic health, researchers emphasize that more studies are needed to confirm whether low vitamin D directly causes cancer or is simply associated with it.
A major study of over 630,000 people found that adults with vitamin D deficiency had a 53% higher risk of developing pancreatic cancer compared to those with healthy vitamin D levels. Researchers also discovered that people with very low vitamin D were at even greater risk. The study, published in the European Journal of Cancer Prevention, tracked patients over 10 years and found similar patterns with pancreatitis (inflammation of the pancreas). While these findings are important, researchers emphasize that more studies are needed to prove vitamin D deficiency directly causes pancreatic cancer.
Key Statistics
A 2026 retrospective cohort study of 633,362 adults published in the European Journal of Cancer Prevention found that vitamin D deficiency was associated with a 53% increased risk of pancreatic cancer over 10 years compared to people with healthy vitamin D levels.
Among patients with severe vitamin D deficiency (below 10 ng/ml), the risk of pancreatic cancer more than doubled, with a 125% increased risk compared to those with adequate vitamin D levels, according to the same 2026 study.
The 2026 study also found that vitamin D deficiency was associated with a 103% increased risk of acute pancreatitis and a 128% increased risk of chronic pancreatitis, suggesting vitamin D plays a broader protective role in pancreatic health.
In the 2026 cohort study, the dose-response pattern showed stronger cancer associations at lower vitamin D levels, with results remaining consistent across different age groups and between men and women.
The Quick Take
- What they studied: Whether people with low vitamin D levels are more likely to develop pancreatic cancer over time
- Who participated: Over 633,000 adults age 40 and older from a global medical database, split into two groups: those with vitamin D deficiency (less than 20 ng/ml) and those with healthy levels (30 ng/ml or higher)
- Key finding: People with vitamin D deficiency were 53% more likely to develop pancreatic cancer within 10 years. Those with severe deficiency (less than 10 ng/ml) had an even higher risk—125% more likely than people with adequate vitamin D
- What it means for you: Maintaining healthy vitamin D levels may help reduce pancreatic cancer risk, though this study cannot prove vitamin D deficiency causes cancer. Getting your vitamin D checked and maintaining adequate levels is a reasonable health precaution, especially as you age
The Research Details
Researchers used a retrospective cohort study design, meaning they looked back at medical records from 2010 to 2023 to compare two groups of people. They identified adults with at least two vitamin D measurements and divided them into a deficiency group (vitamin D below 20 ng/ml) and a healthy group (vitamin D at 30 ng/ml or higher). The two groups were carefully matched to be similar in other ways, so differences in cancer risk could be more confidently linked to vitamin D levels.
The researchers followed both groups for 10 years to see who developed pancreatic cancer, acute pancreatitis (sudden pancreas inflammation), or chronic pancreatitis (long-term pancreas inflammation). They used a 2-year waiting period after the vitamin D measurement before counting cancer cases, which helps ensure the vitamin D deficiency came before the cancer, not after.
To check if their results were reliable, researchers also looked at appendicitis (which shouldn’t be related to vitamin D) as a negative control. The fact that appendicitis rates were similar between groups suggests the vitamin D connection to pancreatic problems is real and not just a measurement error.
This study design is stronger than previous research because it followed real patients over time rather than asking people with cancer to remember their past vitamin D levels. The large sample size (over 633,000 people) and careful matching of comparison groups make the findings more trustworthy. The dose-response pattern (worse outcomes with lower vitamin D) and consistent results across different analyses strengthen confidence in the findings.
Strengths: Very large sample size, long follow-up period (10 years), careful statistical matching between groups, multiple sensitivity analyses confirming results, and a negative control outcome that worked as expected. Limitations: This is observational research, so it cannot prove vitamin D deficiency causes cancer—only that they’re associated. People with vitamin D deficiency had fewer healthcare visits, which could mean some cancers were detected later rather than caused by low vitamin D. The study used medical records, so some vitamin D measurements or cancer cases may have been missed.
What the Results Show
Among the 633,362 matched patients (316,681 in each group), vitamin D deficiency was associated with a 53% increased risk of pancreatic cancer over 10 years. This means if 100 people with healthy vitamin D developed pancreatic cancer, about 153 people with vitamin D deficiency would be expected to develop it. The risk was even stronger for people with severe deficiency (vitamin D below 10 ng/ml), who had a 125% increased risk—more than double the risk of those with adequate vitamin D.
The study also found that vitamin D deficiency was linked to higher rates of both acute pancreatitis (103% increased risk) and chronic pancreatitis (128% increased risk). These findings were consistent across different age groups and between men and women, suggesting the vitamin D connection applies broadly.
Interestingly, people with vitamin D deficiency had fewer healthcare visits overall, which could mean their cancers were discovered later in the disease process. However, the negative control outcome (appendicitis) showed no difference between groups, suggesting the vitamin D-cancer connection is real and not simply due to differences in how often people visited doctors.
Beyond pancreatic cancer, the study revealed strong associations between vitamin D deficiency and pancreatic inflammation. Acute pancreatitis risk more than doubled in the deficiency group, and chronic pancreatitis risk more than doubled as well. These findings suggest vitamin D may play a protective role in pancreatic health more broadly. The dose-response pattern—where severe deficiency showed stronger effects than mild deficiency—supports a genuine biological relationship rather than a chance finding.
Previous research on vitamin D and pancreatic cancer has been mixed, with many studies using case-control designs (asking people with cancer about their past vitamin D levels). This retrospective cohort study is stronger because it followed people forward in time and used actual measured vitamin D levels rather than recalled information. The findings align with biological research showing vitamin D helps regulate immune function and cell growth, both relevant to cancer development. However, this is one of the larger studies specifically examining this relationship in a diverse, real-world population.
This study cannot prove that low vitamin D causes pancreatic cancer—only that the two are associated. People with vitamin D deficiency visited doctors less frequently, which could mean their cancers were simply detected at later stages rather than caused by vitamin D deficiency. The study used medical records, so some vitamin D measurements or cancer diagnoses may have been missed or recorded incorrectly. The study included mostly people with access to healthcare and medical records, so results may not apply to all populations worldwide. Researchers did not have information about other factors that might affect cancer risk, such as smoking, diet, or family history.
The Bottom Line
Maintain vitamin D levels above 30 ng/ml through sun exposure, diet, or supplementation (high confidence based on this study plus existing health guidelines). If you’re over 40, ask your doctor to check your vitamin D level, especially if you have risk factors for pancreatic cancer or pancreatitis (moderate confidence). Do not rely on vitamin D supplementation alone as cancer prevention—maintain other healthy habits like not smoking, eating well, and exercising regularly (high confidence based on general cancer prevention guidelines).
Adults over 40 should pay attention to these findings, particularly those with family history of pancreatic cancer, those living in northern climates with limited sun exposure, or those with digestive health concerns. People with existing pancreatitis should discuss vitamin D status with their doctor. This research is less immediately relevant to younger adults, though maintaining healthy vitamin D is beneficial at any age.
Pancreatic cancer typically develops over years, so the protective effects of adequate vitamin D would likely take months to years to meaningfully reduce risk. Pancreatitis symptoms could potentially improve within weeks to months of correcting vitamin D deficiency, though this study doesn’t measure symptom improvement directly.
Frequently Asked Questions
Does low vitamin D cause pancreatic cancer?
This study found an association but cannot prove causation. People with vitamin D deficiency had 53% higher pancreatic cancer risk, but other factors could explain this link. More research is needed to determine if vitamin D deficiency directly causes cancer or if other factors are involved.
What vitamin D level should I aim for to reduce cancer risk?
The study defined healthy vitamin D as 30 ng/ml or higher. Most health organizations recommend maintaining levels between 30-100 ng/ml. Ask your doctor to check your level and recommend appropriate supplementation if you’re deficient.
Can vitamin D supplements prevent pancreatic cancer?
This study suggests maintaining adequate vitamin D may help reduce risk, but supplements alone cannot prevent cancer. Combine vitamin D with other healthy habits like not smoking, eating well, exercising, and regular medical check-ups for best protection.
How much vitamin D do I need daily?
Most adults need 600-800 IU daily, though those with deficiency may need 1000-2000 IU or more. Your doctor can recommend the right dose based on your blood levels and individual health factors.
Who is most at risk for vitamin D deficiency?
People living in northern climates, those with limited sun exposure, older adults, people with darker skin in low-sun areas, and those with digestive disorders face higher deficiency risk. A simple blood test can determine your vitamin D status.
Want to Apply This Research?
- Track vitamin D levels quarterly (every 3 months) if deficient, or annually if normal. Log the specific ng/ml measurement and note sun exposure, supplementation, and any digestive symptoms to identify patterns.
- Set a reminder to get 15-30 minutes of midday sun exposure 3-4 times weekly, or take a daily vitamin D supplement (1000-2000 IU for adults, higher if deficient). Log supplementation in the app and track energy levels and digestive comfort to monitor changes.
- Create a long-term health dashboard showing vitamin D levels over time, pancreatic health markers (any pancreatitis episodes), and overall wellness scores. Set annual goals to maintain vitamin D above 30 ng/ml and schedule yearly check-ins with your healthcare provider to review levels and adjust supplementation as needed.
This research shows an association between vitamin D deficiency and pancreatic cancer risk but does not prove that low vitamin D causes cancer. This article is for educational purposes and should not replace professional medical advice. If you have concerns about pancreatic cancer risk, vitamin D deficiency, or pancreatitis, consult with your healthcare provider. Do not start, stop, or change any supplements or medications without talking to your doctor first. This study cannot be used to diagnose or treat any medical condition.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.